Category Archives: News

Amoneta Diagnostics (a Firalis affiliate) raises funds via Crowdfunding

You can have a part of Amoneta Diagnostics via Crowdfunding operation open now ! Click here to know more. Amoneta develops a biomarker based non-invasive, simple and realiable blood test for early diagnosis of Alzheimer supported by several EU funding. As agreed by the majority of KOLs; "an efficient and simple diagnosis of Alzheimer's Disease…
Read more

New matrices validated on the BIOPRED panel

New matrices validated on the BIOPRED panel Whole Blood EDTA & PBMC cells Now Available! After the launch of our Biopred panel this year, Firalis is proud to announce the validation of new matrices during this Summer.  Recently, Firalis Group has developed a mRNA targeted gene sequencing panel, allowing to quantify 2155 mRNAs in whole blood from…
Read more

Firalis is certified Propel by Illumina for Next-Generation Sequencing (NGS) best practices

Firalis is certified Propel by Illumina for Next-Generation Sequencing (NGS) best practices To ensure the quality of Next-Generation Sequencing services, Firalis recently obtained the Propel Certification from Illumina. This new certification is based on compliance with the Good Laboratory Practices, production of high quality sequencing data and on the qualification of operators of the Illumina…
Read more

Firalis attended BIO-Europe Spring 2017

Firalis attended BIO-Europe Spring 2017, the 11th International Partnering Conference, at Barcelona. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships.…
Read more